Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression

Cancer Research

Volumn 58, Issue 3, 1998, Pages 491-499

  Kurzawa, Holly ^a   Wysocka, Maria ^b   Aruga, Etsuko ^c,d   Chang, Alfred E ^c   Trinchieri, Giorgio ^b   Lee, William M F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 12; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNE DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; IRRADIATION; MITOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL LINE; TUMOR IMMUNITY; VACCINATION;

EID: 0032005134     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Trinchieri, G., and Scott, P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol., 146: 423-431, 1995.
2. Brunda, M. J. Role of IL-12 as an anti-tumor agent: current status and future directions. Res. Immunol., 146: 622-628, 1995.
3. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
4. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., and Lotze, M. T. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol., 153: 1697-1706, 1994.
5. Tahara, H., Zitvogel, L., Storkus, W. J., Zeh, I., McKinney, T. J., Schreiber, H., Gubler, U., Robbins, P. D., and Lotze, M. T. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol., 154: 6466-6474, 1995.
6. Rodolfo, M., Zilocchi, C., Melani, C., Cappetti, B., Arioli, I., Parmiani, G., and Colombo, M. P. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. J. Immunol., 157: 5536-5542, 1996.
7. Coughlin, C. M., Wysocka, M., Kurzawa, H., Lee, W. M. F., Trinchieri, G., and Eck, S. L. B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res., 55: 4980-1987, 1995.
8. Rao, J. B., Chamberlain, R. S., Bronte, V., Carroll, M. W., Irvine, K. R., Moss, B., Rosenberg, S. A., and Restifo, N. P. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J. Immunol., 156: 3357-3365, 1996.
9. Zitvogel, L., Robbins, P. D., Storkus, W. J., Clarke, M. R., Maeurer, M. J., Campbell, R. L., Davis, C. G., Tahara, H., Schreiber, R. D., and Lotze, M. T. Interleukin-12 and B7-1 co-stimulation cooperate in the induction of effective anti-tumor immunity and therapy of established tumors. Eur. J. Immunol., 26: 1335-1341, 1996.
10. Vagliani, M., Rodolfo, M., Cavallo, F., Parenza, M., Melani, C., Parmiani, G., Forni, G., and Colombo, M. P. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. Cancer Res., 56: 467-470, 1996.
11. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. Inhibition of angiogenesis in vivo by interleukin-12. J. Natl. Cancer Inst., 87: 581-586, 1995.
12. Sgadari, C., Angiolillo, A. L., and Tosata, G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein-10. Blood, 87: 3877-3882, 1996.
13. Orange, J. S., Wolf, S. F., and Biron, C. A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol., 152: 1253-1264, 1994.
14. Noguchi, Y., Richards, E. C., Chen, Y-T., and Old, L. J. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc. Natl. Acad. Sci. USA, 92: 2219-2223, 1995.
15. Hess, H., Gately, M., Rude, E., Schmitt, E., Szeliga, J., and Germann, T. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur. J. Immunol., 26: 187-191, 1996.
16. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G., and Colombo, M. CD4 T cells inhibit in vivo CD8-mediated immune response against a murine colon carcinoma transduced with IL-12 genes. Eur. J. Immunol., 25: 137-146, 1995.
17. Song, C. W., Kang, M. S., Rhee, J. G., and Levitt, S. H. Vascular damage and delayed cell death in tumors after hyperthermia. Br. J. Cancer, 41: 309-312, 1994.
18. Arca, M. J., Krauss, J. C., Aruga, A., Cameron, M. J., Shu, S., and Chang, A. E. Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony stimulating factor. Cancer Gene Ther., 3: 39-47, 1996.
19. Wysocka, M., Kubin, M., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P., and Trinchieri, G. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol., 25: 672-676, 1995.
20. Townsend, S. E., and Allison, J. P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
21. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of anti-tumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA4. Cell, 71: 1093-1102, 1992.
22. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete granulocyte-macrophage colony stimulating factor stimulates potent, specific and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539-3543, 1993.
23. Coughlin, C. M., Wysocka, M., Trinchieri, G., and Lee, W. M. F. The effect of interleukin-12 desensitization on the antitumor efficacy of recombinant interleukin-12. Cancer Res., 57: 2460-2467, 1997.
24. Car, B. D., Eng, V. M., Schnyder, B., LeHir, M., Shakov, A. N., Woerly, G., Huang, S., Aguet, M., Anderson, T. D., and Ryffel, B. Role of interferon-gamma in interleukin-12-induced pathology in mice. Am. J. Pathol., 147: 1693-1707, 1995.
25. Tsung, K., Meko, J. B., Peplinski, G. R., Tsung, Y. L., and Norton, J. A. IL-12 induces T helper 1-directed antitumor response. J. Immunol., 158: 3359-3365, 1997.
26. Horvath-Arcidiacono, J. A., Mostowski, H. S., and Bloom, E. T. IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-γ. Int. Immunol., 8: 661-673, 1996.
27. Wiebke, E. A., Rosenberg, S. A., and Lotze, M. T. Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens. J. Clin. Oncol., 6: 1440-1449, 1988.